Prothena Announces Corporate Restructuring

Stock Information for Prothena Corporation plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Prothena Corporation plc

Prothena's Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease
Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint
Prothena Reports First Quarter 2025 Financial Results and Business Highlights
Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson's Disease
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update
Labaton Sucharow LLP and Levi & Korsinsky LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Ordinary Shares of Prothena Corporation plc in In re Prothena Corporation plc Securities Litigation, No. 1:18-cv-06425-ALC
Prothena Announces Appointment of Paula K. Cobb to its Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.